Experimental Novo obesity drug more effective than Wegovy in early trial Researchers have reported that an experimental obesity drug developed by Novo Nordisk has shown greater efficacy compared to Wegovy in an early trial. The drug, which is still in its experimental phase, has displayed promising results in aiding weight loss among participants. This breakthrough … Continue reading Novo Nordisk’s Innovative Obesity Drug Outperforms Competitors in Early Trials